Bayer AG third-quarter revenue and EBITDA beat expectations
Statements (6)
- Bullish
Bayer raised its full-year revenue guidance after the German pharmaceutical and agricultural giant reported better-than-expected results in the third quarter.
- Bullish
Bayer raised its earnings outlook on pharma recovery
- Bullish
Bayer increased its annual revenue targets after a quarterly profit increase.
- Bullish
Bayer raises profit outlook on strong demand for drugs
- Bullish
Bayer reported third-quarter revenue and EBITDA before special items that exceeded market expectations.
- Bullish
Bayer AG reported net sales of €10.1 billion in the third quarter of the year.